FCA
VTYX

FinTrust Capital Advisors’s Ventyx Biosciences VTYX Stock Holding History

FinTrust Capital Advisors’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$903 Hold
414
– – ﹤0.01% 1281
2024
Q2 		$957 Hold
414
– – ﹤0.01% 1259
2024
Q1 		$2.28K Hold
414
– – ﹤0.01% 1090
2023
Q4 		$1.02K Buy
+414
New +$3.93K ﹤0.01% 1137

Other funds holding VTYX

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FinTrust Capital Advisors's VTYX Position: Q3 2024 in Review

FinTrust Capital Advisors held its Ventyx Biosciences (VTYX) position steady in Q3 2024 at 414 shares worth $903. The position accounts for ﹤0.01% of the portfolio, ranked #1281.

FinTrust Capital Advisors first reported a position in VTYX in Q4 2023 and has held it in 4 quarters since. The position peaked at $2.28K in Q1 2024. 118 funds tracked by Wall St. Rank hold VTYX as of Q3 2024.

  • FinTrust Capital Advisors held 414 shares of Ventyx Biosciences worth $903 as of Q3 2024.
  • FinTrust Capital Advisors left its Ventyx Biosciences share count unchanged in Q3 2024.
  • Ventyx Biosciences made up ﹤0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #1281 holding.
  • FinTrust Capital Advisors first reported a position in Ventyx Biosciences in Q4 2023 and has held it in 4 quarters since.
  • FinTrust Capital Advisors's Ventyx Biosciences position peaked at $2.28K in Q1 2024.
  • 118 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.